Lisinopril

Research use only, not for human use.

A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.

A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.Hypertension Approved.

Lisinopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Lisinopril may be used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals following myocardial infarction, and to prevent progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.

——

MK-521 | MK-522

Metabolic Enzyme/Protease

ACE

ACE

Cardiovascular Disease

Hypertension

76547-98-3

405.4879

C21H31N3O5

>98% (HPLC)

10 mM in DMSO

C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O

L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-

(-20℃)

With Ice Pack

≥ 2 years